Skip to main content
. 2024 Feb 8;7(4):e202302323. doi: 10.26508/lsa.202302323

Table 2.

Significantly differentially abundant urinary cytokines between the never and relapse groups.

IL-1β MCP-1 IL-8 IL-18 IL-13 IL-4
Raw (pg/ml) Never 1.5 (1.5–3.2) 35.13 (1.9–167.4) 7.6 (2–12.7) 22.14 (12.4–52.5) 1.4 (1.4–7.68) 1
Relapse 35.57 (7.6–152.8) 271.6 (72.1–519) 825.4 (130.9–1789) 106 (69.79–319.2) 1.4 1
P-value <0.000001 0.000425 <0.000001 0.000001 0.03134 0.227390
Fold-change 23.4 7.73 108.6 4.78 1 1
Normalized (pg/μg) IL-1β/Cr MCP-1/Cr IL-8/Cr IL-18/Cr IL-13/Cr IL-4/Cr
Never 0.003 (0.001–0.01) 0.065 (0.007–0.18) 0.012 (0.006–0.04) 0.0476 (0.029–0.104) 0.0052 (0.002–0.008) 0.00281 (0.001–0.005)
Relapse 0.058 (0.01–0.22) 0.389 (0.21–0.49) 0.940 (0.17–2.56) 0.157 (0.093–0.376) 0.0021 (0.001–0.004) 0.00129 (0.0009–0.002)
P-value 0.000050 0.000078 <0.000001 0.000017 0.002867 0.038516
Fold-change 19.3 5.98 78.3 3.29 0.4 0.46

Raw and normalized median and interquartile range for each significant cytokine. P-values generated by the Mann–Whitney U test. Fold-change was calculated as a ratio of the median cytokine concentration in the relapse group and the median value in the never group.